X

Trial Profile

A Double-blind, Placebo-controlled, Randomized Trial to Study the Viaskin Peanut's Efficacy and Safety for Treating Peanut Allergy in Children and Adults.

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 29 Oct 2021

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Peanut allergy immunotherapy (Primary)
Indications Peanut hypersensitivity
Focus Therapeutic Use
Acronyms VIPES
Sponsors DBV Technologies

Most Recent Events

14 Nov 2017 Results published in the JAMA: the Journal of the American Medical Association
06 Mar 2017 Results presented at the 2017 Annual Meeting of the American Academy of Allergy, Asthma and Immunology
11 Nov 2016 According to a DBV Technologies media release, additional biomarker data based on VIPES and OLFUS-VIPES trials were presented at the American College of Allergy, Asthma, and Immunology (ACAAI) 2016 meeting.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com